Notably, ATF4, CHOP, and eIF2 subunit gamma (EIF2S3) expression were found to significantly increase with the advancement of HCC to later stages, in line with the possible role of these markers in HCC chemoresistance [18,42,43,44]. This evidence concerns the gene EIF2S3 and hepatocellular carcinoma.